1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries is sponsored by Cures Within Reach. This program provides grants for scientists and clinicians in LMICs who are investigating how currently approved therapies can be repurposed for the treatment of unsolved diseases in their own communities, aiming to expand clinical research in LMICs, address local health concern…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
2026 ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries by Cures Within Reach | Atom Grants 2026 ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries Funds clinical trials in LMICs that repurpose existing therapies for unsolved, high-burden diseases, with a strong emphasis on community engagement.
Funder: Cures Within Reach Due Dates: April 10, 2026 : Letter of Intent (LOI) submission deadline (11:59pm U.S. Eastern Time) Funding Amounts: Up to US$70,000 per trial (plus up to US$8,500 for community engagement); project duration up to 36 months; up to 20% indirect costs allowed.
Summary: Supports clinical repurposing trials led by underresourced researchers in low and lower-middle income countries to develop affordable treatments for unsolved diseases, emphasizing community engagement. Key Information: Application must be led by LMIC-based researchers; AI-generated proposals are not accepted.
This opportunity from Cures Within Reach funds clinical repurposing trials led by underresourced researchers and clinicians based in low and lower-middle income countries (LMICs), as defined by the World Bank. The program aims to build clinical research capacity in LMICs and accelerate the discovery of affordable, available treatments for unsolved diseases affecting these regions.
Projects should utilize already-approved therapies (such as generic drugs, nutraceuticals, indigenous, or combination therapies) in new disease indications where there is unmet medical need. A strong preference is given to trials targeting high-burden diseases (including both communicable and non-communicable diseases, maternal, neonatal, nutritional diseases, or injuries).
All projects must include plans for robust community engagement that go beyond patient involvement, involving community-based organizations, leaders, or groups. See the full grant listing
According to the current listing, eligibility includes: Underresourced researchers in any LMIC (as defined by the World Bank) leading clinical repurposing trials in any disease. Confirm the full requirements in the official notice before applying.
The current listing shows up to $70,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries is funded by Cures Within Reach. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Clinical Repurposing for Veterans Initiative is sponsored by Cures Within Reach. This initiative focuses on finding and funding clinical repurposing trials that address unmet and high-priority medical needs of veterans and active military, including brain injuries. This is a very strong fit for a nonprofit focused on neurological conditions and veterans.
Funding Opportunities / RFPs (Cures Within Reach) is sponsored by Cures Within Reach. Cures Within Reach's mission is to improve patient quality and length of life by leveraging the speed, safety and cost-effectiveness of testing already approved therapies for new indications that serve philanthropic and/or commercial uses, driving more treatments to more patient…
AI Validation - Clinical Trials to Validate AI-Driven Drug Repurposing is sponsored by Cures Within Reach. This program supports investigator-initiated, proof-of-concept, Phase I or Phase IIA clinical trials to validate AI-driven repurposing opportunities for approved therapies in any unsolved disease. Eligible trials must include AI-generated data as part of the preclinical support.
On July 30, 2026, five food and farming nonprofits sued USDA in the Western District of Washington over grant terms and conditions that restrict what grantees may say and do — including with money that never came from the federal government. Twenty states and DC filed a parallel challenge in March. Here is what the conditions actually say and what recipients should do before their next award letter arrives.
Read articleHRSA-26-078 splits $9.1 million among roughly 10 Public Health Training Centers, with awards up to $910,000 and applications due July 17, 2026. Eligibility runs to accredited schools of public health and other nonprofit training institutions. Here's why the winning applications are the ones that can prove an existing, mapped relationship with state and local health departments — not the ones promising the slickest coursework.
Read articleThe Department of Education's May 19 final rule activates Workforce Pell on July 1, 2026, opening federal aid to short-term training programs as brief as 8 weeks. Governors and state workforce boards — not accreditors — pick the eligible industries, and only programs that pass earnings-vs-cost gates make the list.
Read article